View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 20, 2017updated 01 Dec 2021 1:08pm

Deals this week: Hugel, Guangdong Zhongsheng Pharmaceutical, Valeant Pharmaceuticals International

South Korean pharmaceutical company Hugel has announced the private placement of 985,217 common stock shares priced at KRW360,001.9 ($316.2) a share to raise KRW354.68bn ($311.52m) in gross proceeds.

South Korean pharmaceutical company Hugel has announced the private placement of 985,217 common stock shares priced at KRW360,001.9 ($316.2) a share to raise KRW354.68bn ($311.52m) in gross proceeds.

Chinese pharmaceutical company Guangdong Zhongsheng Pharmaceutical has announced a public offering of medium-term notes due 2022 to raise up to CNY1.3bn ($191.64m) in proceeds.

Valeant Pharmaceuticals International has announced plans to divest its speciality drug business, Obagi Medical Products, to China-based fund Haitong International Zhonghua Finance Acquisition, for $190m.

“Chinese pharmaceutical company Guangdong Zhongsheng Pharmaceutical has announced a public offering of medium-term notes due 2022 to raise up to CNY1.3bn ($191.64m) in proceeds.”

The Canadian speciality pharmaceutical company will use the proceeds from the divesture to repay its term loan.

Thermo Fisher Scientific has announced three public offerings of floating rate senior notes and senior notes to raise €2.6bn ($2.98bn) in total.

The floating rate senior notes are due July 2019, while the senior notes are due 23 January 2026, 24 July 2029 and 24 July 2037, and carry a rate of 1.4%, 1.95% and 2.875% respectively.

Thermo Fisher is an equipment, analytical instruments and reagents provider based in the US.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU